Next-Generation Sequencing–Guided Treatment of BRCA2-Mutant Metastatic Uterine Leiomyosarcoma With Poly(ADP-ribose) Polymerase Inhibitor Therapy. This evidence concerns the gene BRCA2 and leiomyosarcoma.